CLINICAL_TRIALS
trial_result
· 2014-02-21
Clinical Trial Update: Monotherapy Study of MP-513 in Patients With Type 2 Diabetes [Phase 3]
Summary
Completion of a Phase 3 monotherapy trial of MP-513 in patients with Type 2 Diabetes; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-02-21